Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kling Douglas F
Chief Operating Officer at NewAmsterdam Pharma Co N.V. Filing since 27 Jan 2025.
CIK 0001699022
Company
Date
Role
Action
Shares
Amount
Of holding
NAMS
NewAmsterdam Pharma Co N.V.
16 Jul 2025
Chief Operating Officer
Sold on a plan
51,043
$1.08M
53.7%
NAMS
NewAmsterdam Pharma Co N.V.
15 Jul 2025
Chief Operating Officer
Sold on a plan
47,569
$1.02M
51.9%
NAMS
NewAmsterdam Pharma Co N.V.
16 Jun 2025
Chief Operating Officer
Sold on a plan
100,000
$1.93M
69.4%
NAMS
NewAmsterdam Pharma Co N.V.
15 May 2025
Chief Operating Officer
Sold on a plan
100,000
no price
69.4%
NAMS
NewAmsterdam Pharma Co N.V.
15 Apr 2025
Chief Operating Officer
Sold on a plan
100,000
no price
69.4%
NAMS
NewAmsterdam Pharma Co N.V.
26 Mar 2025
Chief Operating Officer
Sold at will
16,539
no price
27.3%
NAMS
NewAmsterdam Pharma Co N.V.
17 Mar 2025
Chief Operating Officer
Sold on a plan
100,000
no price
69.4%
NAMS
NewAmsterdam Pharma Co N.V.
19 Feb 2025
Chief Operating Officer
Sold on a plan
9,218
no price
17.3%
NAMS
NewAmsterdam Pharma Co N.V.
18 Feb 2025
Chief Operating Officer
Sold on a plan
90,782
no price
67.4%
NAMS
NewAmsterdam Pharma Co N.V.
30 Jan 2025
Chief Operating Officer
Sold on a plan
13,578
no price
23.6%
NAMS
NewAmsterdam Pharma Co N.V.
29 Jan 2025
Chief Operating Officer
Sold on a plan
56,863
no price
56.4%
NAMS
NewAmsterdam Pharma Co N.V.
28 Jan 2025
Chief Operating Officer
Sold on a plan
25,385
no price
36.6%
NAMS
NewAmsterdam Pharma Co N.V.
27 Jan 2025
Chief Operating Officer
Sold on a plan
104,174
no price
70.3%
13 decisions on file.
